By accessing data from different laboratories, we can gather that the RyR2 itself may be more active in HF due to several post-translational modifications such as oxidation, enhanced phosphorylation at the CaMKII site, as well as a depressed FKBP12.6 expression/binding to RyR2. The gene discussed is RYR2; the disease is hydrops fetalis.